Millions of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that harm the ozone layer. An advisory panel voted 11-7 Tuesday to recommend that the Food and Drug Administration [FDA] remove the essential use" status that Primatene Mist and other similar nonprescription inhalers require to be sold, spokeswoman Laura Alvey said. Final revocation of that status would mean a de facto ban on their sale. Wyeth Consumer Healthcare estimates that 3 million Americans use Primatene Mist for mild or intermittent cases of asthma. About two-thirds also use a prescription inhaler but rely on Primatene as a backup. Another 700,000 use the inhalers because they don't have a prescription or lack health insurance.
Latest
Latest News
Each news summary is created according to strict standards. Here's how we do it.
Each summary is created using a consistent editorial procedure. The target length is approximately 16 lines of 11-point Arial text in a 650-pixel-wide column. Up to 25% of a summary may be set in bold to emphasize the most important ideas. Summaries are composed of verbatim excerpts presented in the same sequence as they appear in the original news source, with very minor editorial additions. Where material has been omitted between excerpts, the omission is indicated with ellipses (...). Any words added by an editor for clarity or context appear in [brackets]. Our original news editor was Fred Burks. Tod Fletcher edited most summaries from 2007 through 2014, and Mark Bailey has served as news editor since 2014.